Genomic testing has become an essential tool in cancer diagnosis and treatment planning. By analyzing the genetic mutations and expression profiles of a tumor, doctors can identify the most effective targeted therapies and predict patient prognosis. Techniques such as next-generation sequencing (NGS) allow for comprehensive analysis of multiple genes simultaneously, providing a detailed understanding of the genetic landscape of a tumor.
